NRGV vs HYPR vs FLNC vs PRCT

For growth investors, Energy Vault Holdings, Inc.

(NRGV) is the stronger pick with 340. 9% revenue growth year-over-year, versus -16. 1% for Fluence Energy, Inc. (FLNC). Analysts rate Energy Vault Holdings, Inc. (NRGV) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, PROCEPT BioRobotics Corporation (PRCT) delivered a total return of -39.

3%, compared to -83. 1% for Hyperfine, Inc. (HYPR). Over 10 years, the gap is even starker: PRCT returned -39. 3% versus HYPR's -83. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), PROCEPT BioRobotics Corporation (PRCT) is the lower-risk stock at 1.

23β versus Fluence Energy, Inc. 's 3. 55β — meaning FLNC is approximately 187% more volatile than PRCT relative to the S&P 500. On balance sheet safety, PROCEPT BioRobotics Corporation (PRCT) carries a lower debt/equity ratio of 14% versus 107% for Energy Vault Holdings, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Energy Vault Holdings, Inc.

(NRGV) is pulling ahead at 340. 9% versus -16. 1% for Fluence Energy, Inc. (FLNC). On earnings-per-share growth, the picture is similar: Energy Vault Holdings, Inc. grew EPS 28. 6% year-over-year, compared to -408. 3% for Fluence Energy, Inc.. Over a 3-year CAGR, PRCT leads at 60. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Fluence Energy, Inc.

(FLNC) is the more profitable company, earning -2. 1% net margin versus -262. 3% for Hyperfine, Inc. — meaning it keeps -2. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FLNC leads at -2. 0% versus -273. 4% for HYPR. At the gross margin level — before operating expenses — PRCT leads at 63. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, PROCEPT BioRobotics Corporation (PRCT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

23)). Hyperfine, Inc. (HYPR) carries a higher beta of 2. 63 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PRCT: -39. 3%, HYPR: -83. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (NRGV (Utilities) and HYPR (Healthcare) and FLNC (Utilities) and PRCT (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: NRGV is a small-cap high-growth stock; HYPR is a small-cap quality compounder stock; FLNC is a small-cap quality compounder stock; PRCT is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.